A meta-analysis suggests allogeneic stem cell transplantation (allo-SCT) should not be recommended following first-line ...

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

Defining "value" in cancer care goes beyond survival and should encompass patient quality of life metrics, said Coral Omene, MD, PhD, of Robert Wood Johnson Medical School.

The Congressional Budget Office estimates the package would add $2.4 trillion to the national deficit over a decade and leave ...

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

TP53 aberrations and circulating tumor DNA burden were found to be predictors of poor outcomes in high-risk patients with ...

Tariff increases threaten the US economy and health care costs, impacting managed care affordability and member financial ...

Structured exercise programs should be a part of the standard of care for colon cancer following adjuvant chemotherapy, ...

Ivarmacitinib, also known as oral SHR0302, is not yet approved by the FDA, with trials currently exploring its utility in ...

Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations ...

To truly shift the landscape in obesity care, explains Jaime Almandoz, MD, MBA, UT Southwestern, care models and policies ...

Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL ...